Pivotal Response Treatment for Individuals With Intellectual Disabilities
NCT ID: NCT01988623
Last Updated: 2021-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2012-09-11
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pivotal Response Treatment Package for Young Children With Autism
NCT02037022
Treatment Efficacy for Developmental Motor Speech Disorders
NCT02105402
Parent-based Intervention for Language Delayed 2 to 3 Year Olds
NCT03083236
Speech Signals in Stuttering
NCT05668923
Speech Processing in Stuttering
NCT04929184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pivotal Response Treatment (PRT)
Pivotal Response Treatment (PRT)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pivotal Response Treatment (PRT)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female
* Diagnosis of an intellectual disability based on the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), and an expert clinical evaluation
* have historical evidence of significant abnormal developmental milestones as determined by neurological history
* care provider that will reliably bring subject to study visits, and is trustworthy to provide accurate accounts of services provided to the subject
* Participants will have an age range between 2 and 17.11 years of age inclusive
* Male or female
* Diagnosis of a speech delay based on the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), and an expert clinical evaluation
* Preschool Language scale (PLS) score of at least 1 standard deviations below age level (for children in the age range of 2-6.11)
* care provider that will reliably bring subject to study visits, and is trustworthy to provide accurate accounts of services provided to the subject
Exclusion Criteria
* primary diagnosis of Autism Spectrum Disorder (ASD) is exclusionary as determined by the investigators
2 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Hardan
Professor of Psychiatry and Behavioral Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Y. Hardan, M.D.
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-25229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.